AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06010108 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Heroes for Her
Description: Market outreach intervention- daily awareness creation through public market announcements, and distribution of educational fliers in local dialects. Community women will also be involved in the spread awareness through door to door approach. Thee will be repeated radio jingles to promote awareness. Interested women and girls will be provided with screening and vaccination services at a designated community health facility. All samples will be returned to the facility by the women and sent to a designated laboratory for testing. Participants contact information will be collected for follow up
Study NCT06010108 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: The Reach Initiative
Description: School based intervention-The Reach Initiative involves the organisation of the Mother-Daughter Day (MDD) by Mother-Daughter Planning Committee (MDPC) who are volunteer young school girls and their mothers and provision of a Key-Card which is a cervical cancer awareness card attached to a key chain for awareness creation. HPV vaccination and HPV -self sampling will be carried out in private rooms within the venue of the intervention and all samples will be sent to designated laboratory for testing. Participants contact information will be collected for follow up and communication of results
Study NCT06010108 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: W.H.I.T.E project
Description: Community based intervention- This will involve the engagement of women's trade unions and organisations in the community to create awareness and women and girls interested in the uptake of HPV prevention services will be directed to receive these services at a designated community facility accessible to women and girls in the community. Participants contact details will be collected for follow uo and communication of results
Study NCT06010108 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Project Shield
Description: Utilization of community based structures (pharmacy and health center)- The intervention will involve the creation of a branded self-sampling kit for HPV screening and a free vaccination voucher to encourage mother-daughter uptake of cervical cancer prevention measures. Awareness will be raised through banners at the points of access of the vaccines and kits, use of jingles, and the involvement of the Community Development Association (CDA) to help mobilize girls, women and the men. Women and girls will be referred to community health centers to receive the HPV vaccination and carry out the screening
Study NCT06010108 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Project SHADE
Description: Community-based approach- health education of girls and women. The use of a uniquely designed bag Eno Iban to package and distribute the self-collection tool, vaccination of the adolescent girls. Screening and HPV will be provided at designated areas within the community for women and girls. A simple app (d-SHADE) will be used to collect data of the girls and women by the health professionals and volunteers, as well as send the reminders for next screening dates and test results
Study NCT06010108 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Operation Reach Her (ORH) program
Description: Faith based approach- Awareness programs would be conducted in the chosen religious centres to educate women and girls about their health, cervical cancer, its prevention, and the benefits of screening and HPV vaccination. This would be achieved by organizing a  Health Day  for free health check-ups for all members of the congregation. The self-sampling kit would be distributed to women aged 30-65 in mobile tents stationed in churches in Akoka and HPV vaccinations would be administered to girls aged 9-14 in mobile tents stationed at churches and mosques in Akoka, Lagos
Study NCT06010108 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Project Care
Description: Community pharmacy intervention-Trained community volunteers will be involved in creating awareness of HPV prevention services and cervical cancer. There will be distribution of cervical cancer self-sampling kits to community pharmacies which will serve as service points for screening (self-collection point) and vaccination point for girls in the community,
Study NCT05311982 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: DLPFC-R (F4) TDCS
Description: direct current brain stimulation- The study was developed through a triple-blind, crossover, randomized, placebo-controlled clinical trial (dummy tDCS). Participants were randomized into three groups receiving unilateral tDCS in DLPFC-L F3 (Block A), combined tDCS in DLPFC-L (F3) and DLPFC-R (F4) simultaneously (Block B) or sham-tDCS (Block C) with equal electrode configuration guaranteed blindness. After the procedures, each participant received the following intervention in the order ABC, BCA or CAB with a period of 1 week between each one. Each block took 3 weeks, organized into: 1) Assessment; 2) Application of stimulation; 3) Reassessment and washout week. Adding 1 more week of final evaluation, the study totaled the period of 10 weeks. During this period, patients were instructed to continue their behavioral/educational treatment and medication routines.
Study NCT05311982 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: DLPFC-L (F3) and DLPFC-R (F4) TDCS
Description: DLPFC-L (F3) and DLPFC-R (F4) (Bock B)
Study NCT05311982 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: sham-tDCS
Description: sham-tDCS (Block C) with equal electrode configuration guaranteed blindness
Study NCT06132503 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LP-284
Description: LP-284 is a small molecule alkylating agent causing tumor cell death through DNA damage.
Study NCT05892861 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: cognitive stimulation
Description: video education, board games, and 24-hour dietary recall record
Study NCT05892861 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: as usual care
Description: history taking, explain data, and discuss how to control healthy condition
Study NCT05341180 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Polyethylene Glycol
Description: Patients will be advised Anobliss (lidocaine with nifedipine) ointment for local application in the anal canal for one month for relief of pain and anal sphincter spasm. Polyethylene glycol syrup at a dose of 15-30 ml will be used for 2 weeks for relief of acute constipation. Patients will be assessed at 1 week and 1 month and evaluated for primary and secondary outcomes.
Study NCT05341180 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Isabgol + Lactulose
Description: Patients will be advised Anobliss (lidocaine with nifedipine) ointment for local application in the anal canal for one month for relief of pain and anal sphincter spasm. Isabgol husk at a dose of 2 teaspoons in 200 ml of warm water before bedtime and 30 ml of syrup lactulose at bedtime will be used for 2 weeks for relief of acute constipation. Patients will be assessed at 1 week and 1 month and evaluated for primary and secondary outcomes.
Study NCT05203692 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DS-7011a
Description: Intravenous or subcutaneous administration, single dose
Study NCT05203692 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Intravenous or subcutaneous administration, single dose
Study NCT04058977 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Power training
Description: Progressive exercise protocol with focus on velocity of movement
Study NCT04662476 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Vitamin D3
Description: Vitamin D3 supplement
Study NCT04170335 — intervention group
Intervention type: PROCEDURE
Intervention: Bariatric surgery
Description: Patients selected and consented for elective bariatric surgery will undergo standard of care preoperative mammogram, as well as inflammatory markers measurements and breast cancer risk score calculation. Post bariatric surgery the patients will have follow up mammogram, inflammatory markers, and breast cancer risk score calculation
Study NCT05515458 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chiglitazar
Description: Oral single dose 48 mg
Study NCT06167382 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnare
Description: Demographic Survey Form,the Physical Activity Readiness Questionnaire for Everyone (PAR-Q+),Goniometric Measurements, Digital Dynamometer Measurements, Hand Grip Measurements, Hand Reaction Measurements, Dexterity and Function Measurements, Jamar Handheld Dynomometer Measurement, Pinchmeter Measurement, Purdue Pegbord Test, Minnesota Manuel Skill Test, Nelson Hand Reaction Test, Modified Borg Scale
Study NCT06167382 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Device: Arm Ergometer
Description: Participants will sign a consent form approved by the ethics comittee. Before data collection height, weight, daily computer usage time, dominant hand, body mass index, heart rate, blood pressure and saturation values be recored. Before arm ergometer exercise, the muscle strength, hand grip strength, joint range of motion, dexterity and reaction speed will be evaluated. The dexterity and reaction speed will be done with Minnesota Manuel Skill Test, Purdue Pegbord Test and Nelson Hand Reaction Test.Participants will be training at least 24 hours apart at 60%, 70%, and 80% of exercise intensity maximum heart rate on arm ergometer. The tests will repeat at the same time with a maximum deviation of 1 hour on 3 different days. At the end of arm ergometer exercise, the necessary evaluations will be made again and the participants will be rest for 15 minutes. 15 minutes after the participants rested, the necessary evaluations will be made again.
Study NCT06238999 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Restoration of non-carious cervical lesions
Description: Non-carious cervical lesions will be treated with the experimental TM Flow or the well-established Tetric EvoFlow. The treatment workflow is very similar to other flowable composites.
Study NCT06238999 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Restoration of non-carious cervical lesions
Description: Non-carious cervical lesions will be treated with the experimental TM Flow or the well-established Tetric EvoFlow. The treatment workflow is very similar to other flowable composites.
Study NCT06475222 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Study 1: Facial serum with alpha albutin
Description: Applying with facial serum with 2% alpha albutin as active comparator daily for 12 weeks.
Study NCT06475222 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Study 1: Facial serum with Tubtim Chumpae rice extract
Description: Applying with facial serum with Tubtim Chumpae rice extract as experimental intervention daily for 12 weeks.
Study NCT06475222 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Study 2: Facial mask with Hom Pathum rice extract
Description: Applying with facial mask with Hom Pathum rice extract as experimental intervention for 30 min/day, 2 days/week for 12 weeks.
Study NCT06475222 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Study 3: Control jelly
Description: Consumption with control jelly as active comparator at 3.5 g/kg body weight.
Study NCT06475222 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Study 3: Jelly with Tubtim Chumpae rice
Description: Consumption with jelly with Tubtim Chumpae rice as experimental intervention at 3.5 g/kg body weight.
Study NCT05264896 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 5-FU, Leucovorin, Oxaliplatin, Docetaxel
Description: FLOT 4 cycles pre and post radical gastrectomy
Study NCT05264896 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: XELOX
Description: XELOX 8 cycles post radical gastrectomy
Study NCT04926727 — intervention group
Intervention type: OTHER
Intervention: Survey
Description: Observational study
Study NCT04884932 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 30 kHz stimulation (Myomed 932, Enraf-Nonius)
Description: A charge-balanced, symmetric, biphasic sinusoidal current without modulation will be delivered at a frequency of 30 kHz. The stimulation intensity will be defined as that sufficient to produce a strong but comfortable sensation, just below motor threshold, over the median nerve through the electrotherapy device Myomed 932. (Enraf-Nonius, Delft,Netherlands)
Study NCT04884932 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sham stimulation (Myomed 932, Enraf-Nonius)
Description: Sham stimulation will be delivered at a frequency of 30 kHz only during the first 30 seconds.
Study NCT05731531 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: ELECTROGASTROGRAPHY
Description: Electrogastrography as a new tool to customize choice of Bariatric therapies by determining success or failure based on GMA and WLST results has not been studied. GMA measures the normal or depleted gastric ICCs and the WLST measures gastric capacity, objective measures that may be important to predict success of Bariatric procedures and thus to help with patient selection to maximize efficacy and minimize side effects.
Study NCT06243627 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sunscreen C Color 2.0 SPF 70
Description: Sunscreen C color 2.0 SPF 70 will be applied topically on half of the face.
Study NCT06243627 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sunscreen C Color 3.0 SPF 70
Description: Sunscreen C color 3.0 SPF 70 will be applied topically on half of the face.
Study NCT06243627 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sunscreen M Very Light SPF 50
Description: Sunscreen M very light SPF 50 will be applied topically on half of the face.
Study NCT06243627 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sunscreen M Golden Color SPF 50
Description: Sunscreen M golden color SPF 50 will be applied topically on half of the face.
Study NCT05803980 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Fecal microbiota transplantation (FMT)
Description: Single FMT infusion via colonoscopy
Study NCT05803980 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation (FMT)
Description: Single FMT infusion via colonoscopy
Study NCT04969367 — intervention group
Intervention type: OTHER
Intervention: Medical Device Usage and Evaluation
Description: Wear activity monitor (Fitbit)
Study NCT04969367 — intervention group
Intervention type: PROCEDURE
Intervention: Biospecimen Collection
Description: Undergo collection of blood samples
Study NCT04969367 — intervention group
Intervention type: OTHER
Intervention: Questionnaire Administration
Description: Complete questionnaires
Study NCT04969367 — intervention group
Intervention type: OTHER
Intervention: Quality-of-Life Assessment
Description: Complete questionnaires
Study NCT05201235 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MAEVAD
Description: MAEVAD is a training device which aims to improve VA span as a prerequisite for learning to read. By increasing the number of distinct visual elements that can be processed simultaneously during fixation, MAEVAD is intended to improve the reading (accuracy and fluency) and spelling (lexical) performance of dyslexics who have a VA span deficit. MAEVAD is designed to be used in total autonomy by dyslexic children with a VA span disorder. The therapy takes place over 6 weeks with 5 sessions of 15 minutes per week. In order to improve compliance, the therapy has been integrated into le Royaume d'Adelia, a serious game where the child will be able to collect materials at the end of each session that will allow him to create objects to customise a character.
Study NCT05201235 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: DeCaLigne
Description: DéCaLigne is an intervention programme for the discovery of calculation with the number line. The objectives are to improve numerical representations in the form of a number line and to improve addition and subtraction skills. The overall principle is to move numbers or calculation results on a number line. This training does not stimulate VA span or the phonological dimensions involved in reading. This therapy is being adapted to be used in total autonomy at home and to correspond to the MAEVAD therapy in duration (5 sessions of 15 minutes per week for 6 weeks). It has also been integrated into the royaume d'Adelia in order to control the motivational effect of the serious game.
Study NCT04970836 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: recombinant hepatitis B vaccine
Description: Hepatitis B vaccine (Engerix-B) will be administered to the eligible participants by 4 groups. Each case will be tracked for 12 months, at 0, 7-10 days, 28 days, 24-28 weeks, 48-52 weeks anti-HBs titer concentration and 4 follow-up questionnaires.
Study NCT04970836 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: recombinant hepatitis B vaccine
Description: Hepatitis B vaccine (Engerix-B) will be administered to the eligible participants by 4 groups. Each case will be tracked for 12 months, at 0, 7-10 days, 28 days, 24-28 weeks, 48-52 weeks anti-HBs titer concentration and 4 follow-up questionnaires.
Study NCT05256940 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing to Address Suicidal Ideation- Revised (MI-SI-R)
Description: Motivational Interviewing to Address Suicidal Ideation (MI-SI-R) was developed to help Veterans resolve ambivalence about living by increasing the motivation to live, that is delivered in three sessions in person, virtually, or by telephone.
Study NCT05256940 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Enhanced usual care (EUC)
Description: Enhanced usual care (EUC) includes safety plans administered or reviewed by research therapists, care coordination, and access to a 24-hour crisis hotline.
Study NCT05256940 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Enhanced usual care (EUC)
Description: Enhanced usual care (EUC) includes safety plans administered or reviewed by research therapists, care coordination, and access to a 24-hour crisis hotline.
Study NCT04931173 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: IVA+OA versus IVA+MBP+OA
Description: Non-inferiority RCT comparing IVA+OA+MBP vs IVA+OA to reduce surgical site infection following colon surgery
Study NCT06535828 — intervention group
Intervention type: DEVICE
Intervention: AI and mechanic modeling
Description: The data collected from research tests on your blood and tumor samples will be used to develop an AI model for treatment selection.
Study NCT06138561 — intervention group
Intervention type: BEHAVIORAL
Intervention: Geriatric-8 Survey
Description: A screening tool to evaluate frailty and at-risk participants by covering multiple domains that contribute to frailty, including mobility, functional status, pharmacologic burden, and underlying psychologic burden. A total score ranges from 0 to 17 with participants scoring > 14 points are more likely to be fit, or having a better health status, while those scoring 0 - 14 would benefit from further comprehensive geriatric assessment.
Study NCT04628416 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PICO dressing
Description: Use of a portative miniature negative pressure dressing system named PICO® on the split-thickness skin graft of fibula free flap donor sites
Study NCT04628416 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Conventional dressing
Description: use of a conventional dressing (parrafin gauze) on the split-thickness skin graft of fibula free flap donor sites
Study NCT06148714 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Provitalize Natural Menopause Probiotic
Description: Supplement containing a Probiotic blend of Bifidobacterium breve, Lactobacillus Gasseri, and Bifidobacterium animalis subsp. Lactis.
Study NCT06148714 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo comparator containing Pure hydroxypropyl methylcellulose (HPmC) with food dye.
Study NCT06138561 — intervention group
Intervention type: BEHAVIORAL
Intervention: National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Bladder Symptom Index-18 (FBISI-18)
Description: Patient reported, sixteen question survey focused on evaluation of quality of life in patients with bladder cancer.
Study NCT06475222 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Study 3: Jelly with Hom Pathum rice
Description: Consumption with jelly with Hom Pathum rice as experimental intervention at 3.5 g/kg body weight.
Study NCT06138561 — intervention group
Intervention type: BEHAVIORAL
Intervention: Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE®)
Description: Patient-reported questionnaire that evaluates cancer-specific toxicity, developed based upon Common Terminology Criteria for Adverse Events.
Study NCT06091657 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ketamine Hydrochloride
Description: intravenous injection
Study NCT05023317 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Strengths-based linkage to alcohol care
Description: SLAC is a behavioral intervention designed to link persons with substance use/misuse to care
Study NCT05023317 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual care
Description: Usual care consists of brief screening and intervention and/or standard referral to alcohol care
Study NCT05127161 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Broad Implementation of Outpatient Stewardship (BIOS) intervention
Description: The BIOS intervention consists of 3 components: (1) online educational modules covering topics related to appropriate antibiotic prescribing for ARTIs, (2) individualized audit and feedback reports displaying clinicians' rates of antibiotic prescription with peer comparison, (3) facilitation provided by the study team and by health system champions to support effective implementation of the intervention and to encourage clinicians to engage meaningfully in the intervention activities.